$ALXO 4 SEC Filings

Filed On	Filing
18 Aug 2026	Form 4: Lettmann Jason, Director Sold 2,230 shares ($4.3K)
18 Aug 2026	Form 4: Wong Shelly, SVP, FINANCE AND CAO Sold 573 shares ($1.11K)
06 Jul 2026	Form 4: Wong Shelly, SVP, FINANCE AND CAO Sold 1,404 shares ($2.86K)
17 Apr 2026	Form 4: Knight Jeff E., Chief Dev & Operating Officer Granted 800,000 Stock option (right to buy)
17 Apr 2026	Form 4: Klencke Barbara, Chief Medical Officer Granted 100,000 Stock option (right to buy)
23 Mar 2026	Form 4: Lettmann Jason, Director Sold 12,311 shares ($26.7K)
23 Mar 2026	Form 4: Pinto Shelly, SVP, FINANCE AND CAO Sold 903 shares ($1.96K)
05 Mar 2026	Form 4: Klencke Barbara, Chief Medical Officer Granted 700,000 Stock option (right to buy)
20 Feb 2026	Form 4: Pinto Shelly, SVP, FINANCE AND CAO Sold 565 shares ($1.28K)
19 Feb 2026	Form 4: Lettmann Jason, Director Gave up 2,201 shares to cover exercise price or tax ($5K)
04 Feb 2026	Form 4: Goodman Corey S, Director Bought 3,184,713 shares ($5M)
28 Jan 2026	Form 4: Shantharam Harish, Chief Financial Officer Granted 303,000 Stock option (right to buy)
28 Jan 2026	Form 4: Pinto Shelly, SVP, FINANCE AND CAO Granted 192,000 Stock option (right to buy)
28 Jan 2026	Form 4: Lettmann Jason, Director Granted 912,000 Stock option (right to buy)
21 Jan 2026	Form 4: Goodman Corey S, Director Granted 40,400 Stock Option (right to buy)
21 Jan 2026	Form 4: Garland J. Scott, Director Granted 40,400 Stock option (right to buy)
21 Jan 2026	Form 4: Sandler Alan B., Director Granted 10,100 Stock option (right to buy)
21 Jan 2026	Form 4: Curran Daniel J., Director Granted 16,833 Stock Option (right to buy)
21 Jan 2026	Form 4: Takimoto Chris H, Director Granted 40,400 Stock option (right to buy)
21 Jan 2026	Form 4: Hemrajani Rekha, Director Granted 40,400 Stock option (right to buy)

Comments